Previous Article | Next Article ![]()
Journal of Bacteriology, June 2004, p. 3674-3676, Vol. 186, No. 12
0021-9193/04/$08.00+0 DOI: 10.1128/JB.186.12.3674-3676.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Cornell University, Ithaca, New York
|
|
|---|
Most known bacterial signaling systems fall into two classes. Gram-positive bacteria typically communicate using oligopeptide signals that are detected by two-component phosphorelay pathways (8), while proteobacteria generally signal via acyl-homoserine lactones (AHLs) that are synthesized by proteins that resemble LuxI of Vibrio fischeri and are detected by transcription factors that resemble LuxR of V. fischeri. These systems are sometimes referred to as quorum-sensing regulators, which suggests that the purpose of these systems is to estimate population density. It is unfortunate that this term is used so freely, since there is little or no evidence that the purpose of any of these signaling systems is to take a bacterial census. It is just as likely that these systems are designed to coordinate the behavior of cell populations rather than to enumerate them.
The signaling system of V. harveyi does not resemble either of the family systems described above. Instead, V. harveyi signals using AI-2 and another chemical signal called AI-1 (1, 2). AI-1 is 3-hydroxy-butanoylhomoserine lactone, which is a member of the family of AHL signals (3). Surprisingly, the AI-1 synthase (LuxM) does not resemble members of the LuxI family, although it is a member of a second small family of synthases that so far has been found only in the genus Vibrio. Detection of AI-1 requires a membrane-spanning two-component kinase (LuxN), while detection of AI-2 requires a periplasmic protein that resembles the ribose binding protein (LuxP) (2) and a second two-component kinase (LuxQ) (1, 2). Both LuxN and LuxQ are hybrid proteins containing a sensor kinase domain and a response regulator domain that funnel phosphoryl groups via LuxU to LuxO, a
54-dependent transcriptional activator that is hypothesized to control the expression of an unidentified repressor of luxR. LuxR (not related to the V. fischeri LuxR protein) activates the luciferase structural operon (luxCDABE) (2, 9, 16). In the absence of both signals, the LuxN and LuxQ proteins act as kinases and the resulting phosporyl-LuxO blocks luminescence. In the presence of signals, the proteins act as phosphatases and the ultimate dephosphorylation of LuxO stimulates luminescence. Both signals are needed for bioluminescence, because in the absence of one signal the cognate receptor acts as a potent kinase to block lux gene expression (20).
For a number of years, the gene directing synthesis of AI-2 remained undiscovered. In 1999, the luxS gene was identified in V. harveyi and a very similar gene was described in Salmonella enterica serovar Typhimurium (29). Since that time luxS genes have been found in dozens of bacterial genera, and the structures of four LuxS proteins have been determined by X-ray crystallography (11, 15, 21). LuxS catalyzes a step in the turnover of S-adenosyl methionine (SAM) (22, 23). When SAM is used as a methyl donor, S-adenosyl-homocysteine (SAH) is generated as one of the products. The adenyl group of SAH is removed by the Pfs protein, generating S-ribosyl-homocysteine (SRH). The LuxS protein hydrolyzes SRH, forming homocysteine and 4,5-dihydroxy-2,3-pentanedione (DPD), which cyclizes spontaneously to form active AI-2. The precise chemical structure of AI-2 was solved by X-ray crystallography of the ligand-bound form of the AI-2 receptor (LuxP) (4). As predicted, AI-2 consists in part of a cyclized carbohydrate that vaguely resembles ribose, from which it is derived. Unexpectedly, the LuxP structure showed a molecule of borate covalently bonded to the carbohydrate, indicating that AI-2 is a furanosyl borate diester. Boron is an abundant component of seawater, and so it should be available to the bacteria. It was a complete surprise that AI-2 would include borate, and the significance of this finding is unclear.
Perhaps the most striking finding about AI-2 is that it is synthesized by so many bacterial genera. The luxS gene is highly conserved in most groups of bacteria, although it is absent from the alpha proteobacteria (19, 29). Many of the bacteria that encode a luxS gene have been shown to produce AI-2, and in every case tested, disruption of luxS eliminated AI-2 production (6, 12, 14, 17, 26, 31). AI-2 appears to have diverse roles in signaling. Pathogenic Escherichia coli strains increase the expression of a Type III protein translocation system in response to AI-2 (24), and in transcriptional profiling experiments, large numbers of E. coli genes are either up-regulated or down-regulated by this signal (7, 26). AI-2 also controls hemin acquisition genes in Porphyromonas gingivalis (27), the expression of the VirB virulence factor in Shigella flexneri (5), and the secretion of the SpeB cysteine protease virulence determinant of Streptococcus pyogenes (6). The detection of AI-2 by these bacteria is largely uncharacterized, although work from the Bassler lab indicates that S. enterica serovar Typhimurium detects AI-2 by the use of an ABC-type uptake system coupled to a transcriptional repressor that is inactivated by phospho-AI-2. This is fundamentally different from AI-2 detection by V. harveyi (29, 30). Perhaps the most important unanswered question about AI-2 is whether all the bacteria that make it actually use it in signaling, as AI-2 may be released by some bacteria as a waste product rather than a signal.
In the current study from the Bassler laboratory, genes that are regulated by the V. harveyi signaling system were sought by testing a library of random lac fusions for increased or decreased ß-galactosidase expression in the presence of these signals. Eight target genes were identified, including one that encodes a
54-dependent response regulator and another that encodes a hybrid two-component kinase-response regulator. It is interesting that these genes were identified, as the AI-1 and AI-2 transduction circuitry includes both classes of proteins. Another regulated gene identified in the study encodes a methyl-accepting chemoreceptor, suggesting that these signals might influence chemotaxis. These findings indicate that this signaling system regulates diverse functions and lies within a signal transduction cascade.
The current study focuses on another group of genes that are regulated by AI-1 and AI-2. These genes encode a TTS system. TTS systems are found in a wide variety of bacterial pathogens (as well as the plant symbiotic bacteria Rhizobium spp.) and mediate the translocation of so-called effector proteins from bacteria directly into the host cell cytosol. These effector proteins act in a variety of ways to enhance the survival of the bacteria and their colonization of the host. Sequence analysis indicates that all TTS systems share a common ancestry and that they all evolved from the basal body of the bacterial flagellum (10). The genes that encode TTS systems are frequently clustered on pathogenicity islands that are known or suspected to engage in horizontal transfer. In the current study from the Bassler laboratory, the TTS system of V. harveyi was shown to be functional by demonstration that a protein called VopD, which resembles YopD of Yersinia enterocolitica, is released from the cells in strains containing an intact secretion system but not from those in mutant strains.
V. harveyi was not previously known to encode a TTS system. However, the closely related human pathogen V. parahaemolyticus was predicted by genomic sequencing to have such a system. The authors showed that the V. parahaemolyticus system was functional by showing that it too could secrete VopD. Furthermore, the V. parahaemolyticus system was shown to be regulated by the orthologous AI-1 and AI-2 signaling system found in this organism.
This is not the first report of a TTS system being regulated by diffusible signals, since the corresponding systems of enteropathogenic E. coli and enterohemorrhagic E. coli are regulated by AI-2 (26-28). In E. coli, however, AI-2 stimulates expression of these genes whereas in the Bassler study, AI-2 (and AI-1) inhibited expression. In another study of an enterohemorrhagic E. coli strain, the SdiA protein (homologous to the LuxR protein of V. fischeri) was observed to inhibit expression of the genes required for pedestal formation (13). Evidence for a signaling molecule was provided, although the signal was not identified. While SdiA appears able to detect a variety of AHL signals (18, 25), E. coli is not known to synthesize any AHLs (18). Thus, the natural signal detected by SdiA remains unknown.
It is not difficult to imagine how V. harveyi could regulate lux genes and TTS genes in a reciprocal manner. It is highly plausible, for example, that LuxR could activate the former genes but repress the latter. This could be accomplished simply by the positioning of the LuxR binding site with respect to the two promoters. The interesting question is not how but why these genes are regulated reciprocally. One might naively think that secretion of effector proteins would occur only at population densities sufficiently high for signaling. Here the AI-1 and AI-2 signals provide information to stop protein translocation. That is to say, it appears that solitary cells inject proteins into host cells whereas populations of cells do not. It must follow that in these Vibrio species, protein injection must occur at the very outset of host colonization before significant bacterial cell division.
Research in my laboratory is supported by grants from the National Institutes of Health (GM42893) and from the National Science Foundation (MCB-9904917). The views expressed in this commentary do not necessarily reflect the views of the journal or of ASM.
The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»